bpc-157 fda warning letter unapproved new drug issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of size:5mg*10vials seal-no-artificial-flavors bpc-157 human clinical trials

bpc-157 fda warning letter unapproved new drug issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of size:5mg*10vials seal-no-artificial-flavors bpc-157 human clinical trials

bpc-157 human clinical trials safety fda warning approval status studies Status: Is It Approved for

this protocol is educational only BPC-157 is a synthetic peptide modeled after a sequence found in gastric proteins and has been explored in preclinical research for its potential influence on nitric oxide signaling, angiogenesis, and collagen-related repair pathways

seal-no-artificial-flavors

size:5mg*10vials

None have been validated in a fibromyalgia-specific RCT as of 2026